Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patterns prevalence use vivelle® estraderm® oral premarin among women 45 years
… based on COA endpoints Gap analysis of data supporting the use of COAs for your intended purpose Collection of …
… Food and Drug Administration (FDA) strongly encourages the use of PROs in clinical trials to accurately assess treatment …
RTI receives Cigna Healthy Workforce Designation ™ Share on: March 3, 2023 Image Cigna has selected nonprofit research institute RTI International, parent company of RTI Health Solutions, as a recipient of their silver level Healthy Workforce Designation …
… Jin Yang Market Access and Outcomes Strategy Vaccines Women's Health Rheumatology Ophthalmology Oncology Infectious … New York at Oneonta, Oneonta, NY Jin Yang has more than 12 years of experience working in medical communications and has … pain, psychiatry, respiratory, rheumatology, and women's health. Prior to joining RTI-HS, she was a medical …
… a project manager at RTI-HS. Ms. Nelson has more than 10 years of project management, risk evaluation and mitigation, … a variety of therapeutic indications, including oncology, women’s health, autoimmune diseases, kidney disease, and …
… as mixing and matching vaccines, boosters, and vaccine use in children are fundamentally changing that landscape. …
Uncovering Factors Associated with Adult Vaccination Coverage in the US Share on: April 28, 2021 Adult vaccination rates in the US are generally low and fall short of public health goals. Given the human and economic burden of vaccine-preventable …
Benefit-Risk Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are used to determine how your patients and other decision-makers perceive the benefits of your treatment features and their tolerance for …
… have existed for a while, HTA organizations have in recent years taken medical technologies under their wings as well. …
… some of the impacts of COVID-19 on the collection and use of clinical outcome assessment (COA) data. They drew …